Disclosure of voting rights | 10/17/2013
RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


RHÖN-KLINIKUM AG 

17.10.2013 09:03

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

B. Braun Holding GmbH & Co. KG, Melsungen, Germany, BraHo
Verwaltungsgesellschaft mbH, Melsungen, Germany, Ludwig G. Braun GmbH & Co.
KG, Melsungen, Germany, Prof. Dr. h.c. Ludwig Georg Braun, Germany, Martin
Lüdicke, Germany, and Ilona Braun, Germany, notified us pursuant to section
25a para. 1 WpHG of the following:

1) On 14 October 2013, B. Braun Holding GmbH & Co. KG exceeded the
threshold of 5% and 10% of the voting rights in RHÖN-KLINIKUM
Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the
voting rights in RHÖN-KLINIKUM Aktiengesellschaft arising from 15,173,376
voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: B.
Braun Melsungen Aktiengesellschaft).

2) On 14 October 2013, BraHo Verwaltungsgesellschaft mbH exceeded the
threshold of 5% and 10% of the voting rights in RHÖN-KLINIKUM
Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the
voting rights in RHÖN-KLINIKUM Aktiengesellschaft arising from 15,173,376
voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: B.
Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft).

3) On 14 October 2013, Ludwig G. Braun GmbH & Co. KG exceeded the threshold
of 5% and 10% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Holding GmbH & Co. KG held 10.98% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: B.
Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft).

4) On 14 October 2013, Prof. Dr. h.c. Ludwig Georg Braun exceeded the
threshold of 5% and 10% of the voting rights in RHÖN-KLINIKUM
Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale,
Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the
voting rights in RHÖN-KLINIKUM Aktiengesellschaft arising from 15,173,376
voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: Ludwig
G. Braun GmbH & Co. KG, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen
Aktiengesellschaft).

5) On 14 October 2013, Martin Lüdicke exceeded the threshold of 5% and 10%
of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding
GmbH & Co. KG held 10.98% of the voting rights in RHÖN-KLINIKUM
Aktiengesellschaft arising from 15,173,376 voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: BraHo
Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun
Melsungen Aktiengesellschaft).

6) On 14 October 2013, Ilona Braun exceeded the threshold of 5% and 10% of
the voting rights in RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1,
97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding
GmbH & Co. KG held 10.98% of the voting rights in RHÖN-KLINIKUM
Aktiengesellschaft arising from 15,173,376 voting rights.
From these voting rights a proportion of 10.98% (equals 15,171,376 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.001% (equals 1,000 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.001%
(equals 1,000 voting rights) is held indirectly. In addition, a proportion
of 0.001% (equals 1,000 voting rights) is based on (financial/other)
instruments pursuant to section 25a WpHG. From the voting rights based on
instruments pursuant to section 25a WpHG a proportion of 0.001% (equals
1,000 voting rights) is held indirectly. The instruments pursuant to
section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with
expiration date 22 December 2014 (chain of controlled undertakings: BraHo
Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun
Melsungen Aktiengesellschaft).

Bad Neustadt a.d. Saale, 17 October 2013

The Board of Management
________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



17.10.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service